Development of tools for early diagnosis of operable cancer
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0003539
- Lead Sponsor
- Kangbuk Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 840
Inclusion Criteria
1. Histologically confirmed malignancy or strongly suspicious malignancy on PET-CT / CT scanning
2. Patients scheduled for curative intended surgery and/or radiotherapy
3. No previous chemotherapy or radiotherapy before curative intended surgery
4. 20 years and older
5. Ability to provide written informed consent for blood sampling
6. Ability to understand the right to withdraw written informed consent without disadvantages
Exclusion Criteria
1. Previous history of chemotherapy and/or radiotherapy and/or curative intended surgery before study enrollment.
2. Previous history of malignancy within 3 years
3. History of organ transplantation requiring immunosuppressive treatment or peripheral blood stem cell transplantation
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Test's average performance using prediction tool in cancer patients (60%);Test's specificity using prediction tool in healthy individuals (99%)
- Secondary Outcome Measures
Name Time Method Sensitivity of mutation enrichment plasma DNA sequencing by tumor type